“…To block potential nonspecific antibody binding, sections were incubated for 30 min using a solution containing 2 % donkey serum, 50 mM glycine, 0.05 % Tween20, 0.1 % TritonX-100, and 0.1 % BSA diluted in PBS. Primary antibody anti-GFAP (1:300, goat/IgG, Abcam, Ab53554) was incubated in an antibody signal enhancer (ASE) solution (Flores-Maldonado et al, 2020; Rosas-Arellano et al, 2016), consisting of 10 mM glycine, 0.05 % Tween20, 0.1 % TritonX-100 and 0.1 % hydrogen peroxide in PBS, and left overnight at 4 °C. For double labeling, GFAP antibody was incubated with 8-hydroxyguanosine (8OHG, marker of RNA oxidation) (1:10000, mouse/IgG, Abcam, ab62623), AT100 (1:500, mouse/IgG, Thermo Scientific, MN1060), and S100A10 (1:250, mouse/IgG, Invitrogen, PIMA515326) primary antibodies.…”